According to FutureWise analysis the market for drug discovery informatics in 2023 is US$ 2.89 billion, and is expected to reach US$ 5.97 billion by 2031 at a CAGR of 9.5%.
The escalating expenditure on research and development, increased usage of informatics for discovering drugs and increased funding for research on rare and chronic diseases are some of the crucial factors responsible for the drug discovery informatics market growth. Conversely, a lack of skilled healthcare personnel and the steep cost of setting up the informatics software shall impede the market growth.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Drug Discovery Informatics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Drug Discovery Informatics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.